Skip to content
Home
About
Services
NAMs Resources
NAMs Insights
Contact
Home
About
Services
NAMs Resources
NAMs Insights
Contact
Posts in July 21, 2026
by
Michael Phelan
July 21, 2026
A CRS Prediction Platform Just Entered ISTAND. It Could Change How Bispecific Antibodies Get to Patients.
Every FDA-approved T cell-engaging bispecific antibody carries a boxed warning for cytokine release syndrome (CRS). Seven […]
0
read more
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website